GeneSpire
Manufacturing · Italy · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Via Visconti Di Modrone 18, Milano, Lomb...Phone Number
+39 280896651Website
www.genespire.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GeneSpire
Genespire is dedicated to developing next-generation gene therapies using immune-shielded lentiviral vectors. The company aims to provide life-changing gene therapy solutions for children affected by genetic diseases. Their mission focuses on enabling these children to benefit from innovative treatments. Genespire operates in the field of gene therapy, targeting clients in need of advanced medical solutions for genetic disorders.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GeneSpire your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on GeneSpire recently announced quarterly report
Funding: Get notified immidiatlly once GeneSpire has new funding data
Check if GeneSpire has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GeneSpire
Product Launch: Get notified when GeneSpire launches new products
Click to see if GeneSpire had a recent Job posting/layoffs
GeneSpire, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if GeneSpire is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at GeneSpire
Find more new buyers
Company Profile Activity
Activity Insights
GeneSpire is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GeneSpire is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GeneSpire.
GeneSpire financials insights
Gather financial insights about GeneSpire, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$12.9M
2024
Series B
$52.1M
GeneSpire Tech Stack
A closer look at the technologies used by GeneSpire
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
GeneSpire News & Media
Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA
Milan, ITALY – 8 May 2025 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces an upcoming oral presentation showcasing critical preclinical insights into dosing for first-in-human in vivo liver-directed immune shielded lentiviral vector (ISLV) gene therapy for methylmalonic acidemia (MMA) at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting to be held May 13-17, 2025 in New OrleaGenespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeneSpire
Sign Up For FreeTo access detailed company insights
Genespire is dedicated to developing next-generation gene therapies using immune-shielded lentiviral vectors. The company aims to provide life-changing gene therapy solutions for children affected by genetic diseases. Their mission focuses on enabling these children to benefit from innovative treatments. Genespire operates in the field of gene ther... Read More
